{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:42:09Z","timestamp":1782135729419,"version":"3.54.5"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Aplastic anemia (AA) is a rare but serious blood disorder defined by autoimmune-driven destruction of bone marrow stem and progenitor cells. HLA polymorphisms are AA risk factors, with population-specific associations influencing disease susceptibility, treatment response, and transplant outcomes. While the genetic pathways driving AA development remain incompletely elucidated, a link between HLA variants and AA predisposition has been documented across diverse ethnic groups, though not in Central Asian communities, particularly in Kazakhstan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We investigated the relationship between HLA Class I and Class II alleles and the risk of AA in the Kazakhstani population using high-resolution NGS genotyping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study included 91 patients with AA and 250 unrelated controls selected from the national registry of hematopoietic stem cell donors. HLA class I (A\/C\/B) and class II (DRB1\/DQA1\/DQB1\/DPB1) high-resolution genotyping was conducted using NGS. Statistical significance was assessed with chi-square tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Class II alleles showed stronger associations with AA than Class I alleles. Novel HLA associations with strong effect sizes (ORs &amp;gt;69) were identified, including the first-ever reported associations between\n                      <jats:italic>HLA-DQA1<\/jats:italic>\n                      alleles and AA susceptibility.\n                      <jats:italic>DRB1*05:05:01<\/jats:italic>\n                      ,\n                      <jats:italic>DRB1*01:02:01<\/jats:italic>\n                      ,\n                      <jats:italic>DQA1*05:05:01<\/jats:italic>\n                      ,\n                      <jats:italic>DQA1*03:03:01<\/jats:italic>\n                      ,\n                      <jats:italic>DQA1*03:02:01<\/jats:italic>\n                      ,\n                      <jats:italic>DQA1*01:04:01<\/jats:italic>\n                      ,\n                      <jats:italic>DQB1*02:02:01<\/jats:italic>\n                      ,\n                      <jats:italic>DPB1*02:01:02<\/jats:italic>\n                      , and\n                      <jats:italic>DPB1<\/jats:italic>\n                      *\n                      <jats:italic>104:01:01<\/jats:italic>\n                      were associated with a higher AA risk in the Kazakhstani population. In contrast,\n                      <jats:italic>DRB1*07:01:01<\/jats:italic>\n                      ,\n                      <jats:italic>DRB1*15:01:01<\/jats:italic>\n                      ,\n                      <jats:italic>DQA1*03:01:01<\/jats:italic>\n                      ,\n                      <jats:italic>DQA1*01:01:01<\/jats:italic>\n                      ,\n                      <jats:italic>DQA1*05:01:01<\/jats:italic>\n                      ,\n                      <jats:italic>DQB1*02:01:01<\/jats:italic>\n                      , and\n                      <jats:italic>DPB1*02:01:01<\/jats:italic>\n                      were linked with reduced risk. Among Class I alleles, only\n                      <jats:italic>B*40:02:01<\/jats:italic>\n                      showed a weak association with increased AA risk (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.042), markedly lower than the strong Class II effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Class II alleles, including those within\n                      <jats:italic>DQA1<\/jats:italic>\n                      and\n                      <jats:italic>DPB1<\/jats:italic>\n                      , are important genetic factors influencing AA susceptibility in Kazakhstan. It highlights the need for region-specific genetic profiling to improve disease risk assessment and guide therapeutic strategies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1752687","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:45:48Z","timestamp":1770273948000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["NGS identifies novel HLA-DQA1 and DPB1 associations with aplastic anemia in the Kazakhstani population"],"prefix":"10.3389","volume":"17","author":[{"given":"Aida","family":"Turganbekova","sequence":"first","affiliation":[{"name":"HLA Laboratory, Scientific and Production Center for Transfusiology","place":["Astana, Kazakhstan"]},{"name":"Faculty of Natural Sciences, L.N. Gumilyov Eurasian National University","place":["Astana, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhulduz","family":"Zhanzakova","sequence":"additional","affiliation":[{"name":"HLA Laboratory, Scientific and Production Center for Transfusiology","place":["Astana, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perizat","family":"Kanabekova","sequence":"additional","affiliation":[{"name":"School of Medicine, Nazarbayev University","place":["Astana, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Baimukasheva","sequence":"additional","affiliation":[{"name":"HLA Laboratory, Scientific and Production Center for Transfusiology","place":["Astana, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhazira","family":"Saduakas","sequence":"additional","affiliation":[{"name":"HLA Laboratory, Scientific and Production Center for Transfusiology","place":["Astana, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didara","family":"Khamitova","sequence":"additional","affiliation":[{"name":"HLA Laboratory, Scientific and Production Center for Transfusiology","place":["Astana, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saniya","family":"Abdrakhmanova","sequence":"additional","affiliation":[{"name":"HLA Laboratory, Scientific and Production Center for Transfusiology","place":["Astana, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaksylyk","family":"Masalimov","sequence":"additional","affiliation":[{"name":"Faculty of Natural Sciences, L.N. Gumilyov Eurasian National University","place":["Astana, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim Y.","family":"Almawi","sequence":"additional","affiliation":[{"name":"Faculty of Sciences, El-Manar University","place":["Tunis, Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.14996","article-title":"Aplastic anaemia: Current concepts in diagnosis and management","volume":"56","author":"Furlong","year":"2020","journal-title":"J Paediatr Child Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"102857","DOI":"10.1016\/j.bcmd.2024.102857","article-title":"Aberrant baseline cytokine profile in patients with newly diagnosed acquired aplastic anaemia correlates with disease severity and the treatment response","volume":"107","author":"Vatsayan","year":"2024","journal-title":"Blood Cells Mol Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-024-03715-1","article-title":"Aplastic anemia: history and recent developments in diagnosis and treatment","volume":"119","author":"Onishi","year":"2024","journal-title":"Int J Hematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.22214.1","article-title":"Novel therapeutic choices in immune aplastic anemia","volume":"9","author":"Scheinberg","year":"2020","journal-title":"F1000Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2024.0045","article-title":"Development of a prediction model for the risk of infection in patients with aplastic anemia: survival analysis in recurrent events","volume":"56","author":"Saelue","year":"2024","journal-title":"Infect Chemother"},{"key":"B7","article-title":"Acute hepatitis as a prequel to very severe aplastic anemia","volume":"56","author":"Weiler-Normann","year":"2018","journal-title":"Z Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1042\/BST20210410","article-title":"The pockets guide to HLA class I molecules","volume":"49","author":"Nguyen","year":"2021","journal-title":"Biochem Soc Trans"},{"key":"B9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/genes16030342","article-title":"Genetic diversity and ethnic tapestry of Kazakhstan as inferred from HLA polymorphism and population dynamics: A comprehensive review","volume":"16","author":"Turganbekova","year":"2025","journal-title":"Genes (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3390\/vaccines10020339","article-title":"Four faces of cell-surface HLA class-I: their antigenic and immunogenic divergence generating novel targets for vaccines","volume":"10","author":"Ravindranath","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/sji.12329","article-title":"Clinical role of human leukocyte antigen in health and disease","volume":"82","author":"Mosaad","year":"2015","journal-title":"Scand J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e13173","DOI":"10.1111\/aji.13173","article-title":"Maternal HLA-DR, HLA-DQ, and HLA-DP loci are linked with altered risk of recurrent pregnancy loss in Lebanese women: A case-control study","volume":"82","author":"Aimagambetova","year":"2019","journal-title":"Am J Reprod Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/tan.12855","article-title":"HLA DRB1\/DQB1 alleles and DRB1-DQB1 haplotypes and the risk of rheumatoid arthritis in Tunisians: a population-based case-control study","volume":"88","author":"Lagha","year":"2016","journal-title":"HLA"},{"key":"B14","first-page":"103358","article-title":"HLA class I and II alleles profile in Indian patients with aplastic anemia","volume":"61","author":"Deng","year":"2022","journal-title":"Transfus Apher Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0162382","DOI":"10.1371\/journal.pone.0162382","article-title":"Association of human leukocyte antigen DRB1*15 and DRB1*15:01 polymorphisms with response to immunosuppressive therapy in patients with aplastic anemia: A meta-analysis","volume":"11","author":"Liu","year":"2016","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e163040","DOI":"10.1172\/jci.insight.163040","article-title":"Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities","volume":"227","author":"Olson","year":"2022","journal-title":"JCI Insight"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1056381","article-title":"Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2020.07.001","article-title":"Association of HLA class II (-DRB1,-DQB1,-DPB1) alleles and haplotypes on susceptibility to aplastic anemia in northern Chinese Han","volume":"81","author":"Qi","year":"2020","journal-title":"Hum Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2014.06.011","article-title":"The polymorphisms of human leukocyte antigen loci may contribute to the susceptibility and severity of severe aplastic anemia in Chinese patients","volume":"75","author":"Wang","year":"2014","journal-title":"Hum Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3513","article-title":"Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH\/aplastic anemia syndrome","volume":"98","author":"Maciejewski","year":"2001","journal-title":"Blood"},{"key":"B21","article-title":"HLA-DRB1*15 and pediatric aplastic anemia","volume":"87","author":"Oguz","year":"2002","journal-title":"Haematologica"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-024-01343-x","article-title":"HLA alleles, haplotypes frequencies, and their association with hematological disorders: a report from 1550 families whose patients underwent allogeneic bone marrow transplantation in Egypt","volume":"76","author":"ElNahass","year":"2024","journal-title":"Immunogenetics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"101559","DOI":"10.1016\/j.beha.2024.101559","article-title":"The most frequent HLA alleles around the world: A fundamental synopsis","volume":"37","author":"Sanchez-Mazas","year":"2024","journal-title":"Best Pract Res Clin Haematol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/tan.14937","article-title":"HLA allele and haplotype frequencies in Kazakhstani Russians and their relationship with other populations","volume":"101","author":"Hajjej","year":"2023","journal-title":"HLA"},{"key":"B25","doi-asserted-by":"publisher","first-page":"msae144","DOI":"10.1093\/molbev\/msae144","article-title":"Ancestral origins and admixture history of Kazakhs","volume":"41","author":"Lei","year":"2024","journal-title":"Mol Biol Evol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(88)90069-8","article-title":"The international agranulocytosis and aplastic anemia study (IAAAS)","volume":"41","author":"Kramer","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exphem.2006.09.002","article-title":"Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia","volume":"35","author":"Sugimori","year":"2007","journal-title":"Exp Hematol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2011.06.013","article-title":"Susceptibility to aplastic anemia is associated with HLA-DRB1*1501 in an aboriginal population in Sabah, Malaysia","volume":"72","author":"Dhaliwal","year":"2011","journal-title":"Hum Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2008.04.009","article-title":"Association of human leukocyte antigen-DRB1 alleles with disease susceptibility and severity of aplastic anemia in Korean patients","volume":"69","author":"Song","year":"2008","journal-title":"Hum Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1423-0127-19-88","article-title":"HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing","volume":"19","author":"Megiorni","year":"2012","journal-title":"J BioMed Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015860","article-title":"HLA-DQ heterodimers in hematopoietic cell transplantation","volume":"139","author":"Petersdorf","year":"2022","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e15700","DOI":"10.1111\/tan.15700","article-title":"Characterisation of the HLA-DQ alpha eplet 52SK targeting the DQA1*01 alleles family","volume":"104","author":"Devriese","year":"2024","journal-title":"HLA"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01913-5","article-title":"Population-specific putative causal variants shape quantitative traits","volume":"56","author":"Koyama","year":"2024","journal-title":"Nat Genet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2024.101562","article-title":"HLA typing: A review of methodologies and clinical impact on haematopoietic cell transplantation","volume":"37","author":"Mayor","year":"2024","journal-title":"Best Pract Res Clin Haematol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.01.004","article-title":"Genome-wide association study identifies HLA-DPB1 as a significant risk factor for severe aplastic anemia","volume":"106","author":"Savage","year":"2020","journal-title":"Am J Hum Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.614976","article-title":"The human leukocyte antigen-DPB1 degree of compatibility is determined by its expression level and mismatch permissiveness: A German multicenter analysis","volume":"11","author":"Mytilineos","year":"2021","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02212-3","article-title":"Using large-scale population-based data to improve disease risk assessment of clinical variants","volume":"57","author":"Forrest","year":"2025","journal-title":"Nat Genet"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012895","article-title":"HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia","volume":"138","author":"Zaimoku","year":"2021","journal-title":"Blood"},{"key":"B39","article-title":"The frequency of HLA class I alleles in Japanese patients with bone marrow failure","volume":"91","author":"Shichishima","year":"2006","journal-title":"Haematologica"},{"key":"B40","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1182\/blood.V128.22.730.730","article-title":"Somatic loss of HLA Class I alleles is a common genetic alteration in acquired aplastic anemia and reveals aplastic anemia risk alleles","volume":"128","author":"Babushok","year":"2016","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6471","article-title":"Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk","volume":"68","author":"Madeleine","year":"2008","journal-title":"Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjhh.2017.02.003","article-title":"Understanding population-wide haplotype frequencies of human leukocyte antigen (HLA) alleles in linkage disequilibrium is important for hematopoietic stem cell transplantation","volume":"39","author":"Otegbeye","year":"2017","journal-title":"Rev Bras Hematol Hemoter"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.11.4.770-774.2004","article-title":"HLA class II profile and distribution of HLA-DRB1 and HLA-DQB1 alleles and haplotypes among Lebanese and Bahraini Arabs","volume":"11","author":"Almawi","year":"2004","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1752687\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:45:50Z","timestamp":1770273950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1752687\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2026.1752687"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1752687","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"article-number":"1752687"}}